Phase 4 Chronic kidney disease trials recruiting now

All Chronic kidney disease trials, every phase

Other phases for Chronic kidney disease

Phase 4 Chronic kidney disease trials

• A Biomarker-targeted Clinical Trial to Optimize Treatment for Patients With Chronic Kidney Disease
  NCT07239570 · Phase: Phase 4 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 4 locations
• A Post Marketing Surveillance to Evaluate the Safety of Desidustat for the Treatment of Anemia in Subjects With Chronic Kidney Disease (CKD).(Real World Evidence Study)
  NCT05515367 · Phase: Phase 4 · Ages: 18 Years to 85 Years · Sex: All (male and female) · 1 location
• A Pragmatic Trial Comparing Empagliflozin and Dapagliflozin Through Cluster Randomization Embedded in the Electronic Health Record
  NCT06642272 · Phase: Phase 4 · Ages: 18 Years and older · Sex: All (male and female) · 12 locations
• ACE Reno, Pico Cell Matrix and Its Effect on eGFR in Chronic Kidney Diseases
  NCT07187713 · Phase: Phase 4 · Ages: 18 Years to 80 Years · Sex: All (male and female) · 1 location
• ASPIrin in Reducing Events in Dialysis ( ASPIRED )
  NCT04381143 · Phase: Phase 4 · Ages: 18 Years and older · Sex: All (male and female) · 139 locations
• Anrikefon vs Nalfurafine for Sleep Quality in Hemodialysis Patients With CKD-aP
  NCT07380113 · Phase: Phase 4 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 1 location
• Blood Pressure Control With Thiazide Diuretics in Peritoneal Dialysis Patients
  NCT07271420 · Phase: Phase 4 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Calcium-Phosphorus Regulation Therapy on Heart Valve Disease
  NCT06660524 · Phase: Phase 4 · Ages: 50 Years and older · Sex: All (male and female) · 1 location
• Correction of Anemia With Enarodustat in Non-dialysis Dependent Chronic Kidney Disease
  NCT06725810 · Phase: Phase 4 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 1 location
• Cosibelimab for CSCC in Patients With Kidney Transplant or Hematologic Malignancy
  NCT07426484 · Phase: Phase 4 · Ages: 18 Years and older · Sex: All (male and female) · 2 locations
• Dapagliflozin on Renal Morphology and Renal Perfusion in Patients One Year After Kidney Transplantation
  NCT06560801 · Phase: Phase 4 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 1 location
• EMPAgliflozin in Heart Failure With PReserved Ejection Fraction and End Stage Renal Disease
  NCT06249945 · Phase: Phase 4 · Ages: 20 Years and older · Sex: All (male and female) · 2 locations
• Effect of Empagliflozin in Patients With eGFR Between 10 and 20 ml/Min/1.73m2
  NCT07074418 · Phase: Phase 4 · Ages: 18 Years to 80 Years · Sex: All (male and female) · 1 location
• Effect of Empagliflozin on Podocyte Specific Proteins in African American Veterans With NDKD
  NCT06110130 · Phase: Phase 4 · Ages: 19 Years to 90 Years · Sex: All (male and female) · 1 location
• Effect of Treatment With Finerenone on Cardio-Renal Target Organ Damage in Patients With Type 2 Diabetes.
  NCT07026539 · Phase: Phase 4 · Ages: 18 Years and older · Sex: All (male and female) · 2 locations
• Effectiveness and Cost-effectiveness of a Pre-emptive Genotyping Strategy in Patients Receiving Tacrolimus
  NCT06701825 · Phase: Phase 4 · Ages: No age limits stated · Sex: All (male and female) · 1 location
• Efficacy and Safety of Extended TARPEYO® Treatment Beyond 9 Months in Adult Patients With Primary IgA Nephropathy
  NCT06712407 · Phase: Phase 4 · Ages: 18 Years and older · Sex: All (male and female) · 38 locations
• Efficacy and Safety of Sodium-Glucose Cotransporter-2 Inhibitors in Adolescents With Early Stages of Chronic Kidney Disease
  NCT07405216 · Phase: Phase 4 · Ages: 14 Years to 18 Years · Sex: All (male and female) · 1 location
• Empagliflozin Treatment in Kidney Transplant Recipients
  NCT06013865 · Phase: Phase 4 · Ages: 19 Years and older · Sex: All (male and female) · 5 locations
• Empagliflozin in Heart Failure with Reduced Ejection Fraction and End Stage Renal Disease
  NCT06249932 · Phase: Phase 4 · Ages: 20 Years and older · Sex: All (male and female) · 4 locations
• Evaluate the Efficacy and Safety of Amino Acid (15) Peritoneal Dialysis Solution in Peritoneal Dialysis Patients with Malnutrition.
  NCT06597201 · Phase: Phase 4 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 21 locations
• Glucagon-like-peptide-1 Receptor Agonists in Patients Receiving Maintenance Dialysis
  NCT07017270 · Phase: Phase 4 · Ages: 18 Years and older · Sex: All (male and female) · 4 locations
• Nefecon and Ambrisentan in IgA Nephropathy
  NCT07030894 · Phase: Phase 4 · Ages: 18 Years to 70 Years · Sex: All (male and female) · 1 location
• Niaoduqing Granules in Older Adults With Impaired Kidney Function
  NCT07741292 · Phase: Phase 4 · Ages: 61 Years and older · Sex: All (male and female) · 1 location
• Obesity Management for Kidney TRANSPLANTation: OK-TRANSPLANT 2
  NCT06396416 · Phase: Phase 4 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Oral Iron in Children With Chronic Kidney Disease
  NCT03991169 · Phase: Phase 4 · Ages: 1 Year to 21 Years · Sex: All (male and female) · 2 locations
• Pegmolesatide Treatment for Anemia in Patients Undergoing Long-term Dialysis
  NCT07045155 · Phase: Phase 4 · Ages: 18 Years to 80 Years · Sex: All (male and female) · 1 location
• Potassium Correction for RAAS Optimization in Chronic Kidney Disease
  NCT06256991 · Phase: Phase 4 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Randomised Evaluation of Sodium Dialysate Levels on Vascular Events
  NCT02823821 · Phase: Phase 4 · Ages: 18 Years and older · Sex: All (male and female) · 264 locations
• Risk of Acute Complications With Rocuronium vs Cisatracurium in Patients With Chronic Kidney Disease
  NCT07203287 · Phase: Phase 4 · Ages: 18 Years to 80 Years · Sex: All (male and female) · 1 location
• Role of Coenzyme Q10 in Chronic Kidney Disease
  NCT05942027 · Phase: Phase 4 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Role of Vitamin K2 in Chronic Kidney Disease
  NCT05942053 · Phase: Phase 4 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Safety of Short-course of NSAIDs in Pediatric Patients With CKD
  NCT06860711 · Phase: Phase 4 · Ages: 18 Months to 25 Years · Sex: All (male and female) · 1 location
• Single and Twice-daily Dosing of Ramipril on Renal Function in Chronic Kidney Disease Patients With Reduced Ejection Fraction Heart Failure
  NCT07259512 · Phase: Phase 4 · Ages: 18 Years and older · Sex: All (male and female) · 2 locations
• Study to Compare the Outcome of Receiving Continued Immunosuppression Versus Stopping Immunosuppression at 6 Months to Safely Prevent Human Leukocyte Antigen (HLA) Sensitization in Patients With Late Renal Graft Failure
  NCT06676696 · Phase: Phase 4 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• The Danish Warfarin-Dialysis Study - Safety and Efficacy of Warfarin in Patients With Atrial Fibrillation on Dialysis
  NCT03862859 · Phase: Phase 4 · Ages: 18 Years and older · Sex: All (male and female) · 13 locations
• The Effect and Mechanism of Xiqing Regulating Intestinal Homeostasis on Drug Efficacy of Chronic Kidney Disease
  NCT07182942 · Phase: Phase 4 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 1 location
• Treatment of Adynamic Bone Disorder With Parathyroid Hormone in Chronic Kidney Disease
  NCT04522622 · Phase: Phase 4 · Ages: 18 Years to 120 Years · Sex: All (male and female) · 4 locations
• Use of Clinical-trials and Simulation Models to Estimate Cost-effectiveness of Non-steroidal Mineralocorticoid Antagonists, RASi and SGLT2i as Triple Therapy With Type 2 Diabetes and Chronic Kidney Disease
  NCT06727409 · Phase: Phase 4 · Ages: 18 Years and older · Sex: All (male and female) · 2 locations
• Use of Pegmolesatide in Renal Anemia: Efficacy and Safety of Switching to Pegmolesatide in Non-dialysis CKD Patients Treated With rhuEPO or HIF-PHI
  NCT06946394 · Phase: Phase 4 · Ages: 18 Years to 80 Years · Sex: All (male and female) · 1 location
• Vitamin K AntagonISt, Factor Xa Inhibitor or No Anticoagulation in Atrial Fibrillation and DIalytic End-stage Renal DiseasE (VISIONAIRE)
  NCT06402851 · Phase: Phase 4 · Ages: 18 Years and older · Sex: All (male and female) · 12 locations
• Which of the Commonly Available and Approved Drugs in Addition to Standard of Care Can Significantly Improve the Slope of Estimated Glomerular Filtration Rate at Two Years When Compared to Standard of Care Alone in South-Asian Kidney Biopsy-proven Adult (≥18 Years) Primary IgA Nephropathy?
  NCT06676384 · Phase: Phase 4 · Ages: 18 Years to 65 Years · Sex: All (male and female) · 12 locations

Common questions

What does Phase 4 mean?

See how clinical trials work.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.